Marit Van Buuren MSc, PhD

Marit M. van Buuren, PhD is a Group Leader at Neon Therapeutics, where she is responsible for NEON’s T cell program, NEO-PTC-01. She performed her graduate work in the lab of Ton Schumacher where she was trained as a tumor immunologist studying the recognition of neoantigens by T cells in patients with melanoma. In her job at Neon therapeutics she uses this expertise to bring neoantigen specific T cell therapies to patients.